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Abstract
Background: Academic institutions play important roles in protecting and preserving research integrity. Concerns
have been expressed about the objectivity, adequacy and transparency of institutional investigations of potentially
compromised research integrity. We assessed the reports provided to us of investigations by three academic
institutions of a large body of overlapping research with potentially compromised integrity.
Methods: In 2017, we raised concerns with four academic institutions about the integrity of > 200 publications co-
authored by an overlapping set of researchers. Each institution initiated an investigation. By November 2018, three
had reported to us the results of their investigations, but only one report was publicly available. Two investigators
independently assessed each available report using a published 26-item checklist designed to determine the quality
and adequacy of institutional investigations of research integrity. Each assessor recorded additional comments
ad hoc.
Results: Concerns raised with the institutions were overlapping, wide-ranging and included those which were both
general and publication-specific. The number of potentially affected publications at individual institutions ranged
from 34 to 200. The duration of investigation by the three institutions which provided reports was 8–17 months.
These investigations covered 14%, 15% and 77%, respectively, of potentially affected publications. Between-assessor
agreement using the quality checklist was 0.68, 0.72 and 0.65 for each report. Only 4/78 individual checklist items
were addressed adequately: a further 14 could not be assessed. Each report was graded inadequate overall. Reports
failed to address publication-specific concerns and focussed more strongly on determining research misconduct
than evaluating the integrity of publications.
Conclusions: Our analyses identify important deficiencies in the quality and reporting of institutional investigation
of concerns about the integrity of a large body of research reported by an overlapping set of researchers. They
reinforce disquiet about the ability of institutions to rigorously and objectively oversee integrity of research
conducted by their own employees.
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Background
The integrity of the biomedical literature is fundamentally
important in ensuring the efficient development of effect-
ive and safe clinical practices. Protecting research integrity
is the responsibility of several protagonists, including indi-
vidual researchers, peers and coinvestigators within re-
search groups, funding bodies, regulatory bodies, journals,
publishers, and institutions that employ research staff and
administer research activities.
Academic institutions can play essential roles in the
protection of research integrity, by providing support-
ive environments and demonstrating best practice [1].
Because institutions have direct access to researchers
they employ and are frequently directly involved in
research administration, they can both investigate
whether research is reliable and determine whether
research misconduct has occurred. Consequently, institu-
tions are frequently involved in cases of suspected com-
promise of research integrity. However, concerns exist
about the reliability, consistency, transparency and com-
pleteness of institutional investigations [2, 3]. Suggestions
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to address these concerns include quality checklists for in-
stitutional investigations and their reports, and independ-
ent peer review and publication of reports [1].
Published research on institutional investigations of re-
search integrity is infrequent. Between 2013 and 2016, we
raised wide-ranging concerns about the integrity of 33
clinical trial reports from a research group in Japan [4]. By
early 2017, as a result of investigations initiated by affected
journals, 12 retractions had ensued, for fabrication,
plagiarism, authorship misconduct and unresolved con-
cerns about data integrity. Contemporaneously, we were
concerned about the integrity of the larger body of
non-randomised and preclinical research reported by the
same group, but to our knowledge, no systematic investi-
gation of this work was being undertaken by publishers of
affected journals, and no institutional investigation had
been undertaken or was underway. Beginning in March
2017, we raised wide-ranging concerns about the integrity
of > 200 publications with the three Japanese and one US
universities of affiliation of the two leaders of the research
group. Here, we assess the reports of the institutional
investigations conducted in response to our concerns.
Methods
We searched the website of each affected institution to
identify staff with responsibility for oversight of research
integrity and communicated by email. Our initial email
to each institution outlined the context of compromised
integrity and retractions of work published by em-
ployees, the publicly available reasons for existing retrac-
tions, the absence of scrutiny of non-randomised and
preclinical research by those employees, and a sugges-
tion that the institution should assess the integrity of all
potentially compromised publications co-authored by
the employees. Detailed concerns about specific publica-
tions were communicated to three of four institutions at
either first contact or in subsequent emails. Each institu-
tion was appraised of the involvement of employees of
the other institutions and that we had raised concerns
with the other institutions. Each institution was also
made aware that we had sent detailed concerns to the
national organisations responsible for research integrity
oversight [Office of Research Integrity (ORI) in the USA;
Ministry of Education, Culture, Sports, Science and
Technology (MEXT) in Japan].
We defined a potentially affected publication as any
paper authored by the primary respondent with at least
one co-author affiliated to the institution. We defined
affected employees as those who co-authored > 5 publi-
cations with the primary respondent.
Each institution initiated an investigation. By 3
December 2018, three had reported their results to us.
Only one report is publicly available [5]. Using a recently
published checklist that was designed by a panel of
experts in the evaluation of research integrity [1], two of
us (AG, MB) independently assessed the quality of each
report and resolved differences by consensus. The check-
list includes an overall assessment, with four categories
that include ‘acceptable as is’, ‘minor revisions needed’,
‘major revisions needed’ and ‘report is not acceptable’.
Results
During correspondence with the institutions, we learned
that two institutions had undertaken investigations prior
to receiving our concerns, but neither was publicly
announced or reported. Institution 1 undertook a pre-
liminary investigation 11/16–1/17, but commenced a full
investigation in March 2017. Institution 2 undertook an
investigation 3/16–1/17 which found ‘improper scientific
(authorship) conduct’ but did not lead to correction of
any affected publications.
The ORI did not acknowledge receipt of emails sent in
October and November 2017 outlining concerns about re-
search conducted at the US institution. Our emails to the
MEXT in November and December 2017 reporting the
concerns about research conducted at the Japanese insti-
tutions, including ones written by a Japanese colleague, ei-
ther failed to elicit a response or generated brief unhelpful
replies, promising a response that has not yet materialised.
Table 1 sets out the timelines of our notification of the
affected institutions, the nature of the concerns raised and
the scope of the concerns. The concerns raised overlapped
between institutions and with those raised in regard to the
clinical trials which were the focus of a published system-
atic review [4]. At each institution, ≥ 2 employees (range
2–6) were co-authors on ≥ 5 potentially affected papers.
The number of potentially affected publications at individ-
ual institutions ranged from 34 to 200.
Table 2 summarises the processes and outcomes of the
investigations by the three reporting institutions, which
took 8–17months. Institution 3 has not reported the out-
comes of its investigation to us or, to our knowledge,
publicly. Institution 2 focused on one employee—it was un-
clear how many were investigated by institutions 1 and 4.
Institutions 1, 2 and 4 investigated 38/49, 7/200 and 5/34
potentially affected papers, respectively. In subsequent cor-
respondence, institution 2 indicated it was investigating
non-clinical research by its employee.
Table 3 shows our assessment of the institutions’ re-
ports. Assessors agreed on 21, 21 and 20 of 26 items in
each report (kappa coefficients 0.68, 0.72 and 0.65, re-
spectively). Consensus resolved the minor differences
that occurred because of ambiguity in the questions in
the Evidence section. Overall, each report was consid-
ered unacceptable by both assessors. In the respective
reports, only 3/26, 1/26 and 0/26 individual checklist
items were addressed adequately: a further 5/26, 5/26
and 4/26 items could not be assessed. Common
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Table 1 Notification, nature and scope of concerns about research integrity raised with four academic institutions
Institution
1 2 3 4
Concerns
Date(s) concerns raised by
our group
14 March 2017 14 March 2017
15 May 2017
11 October 2017
18 November 2017
14 March 2017
18 November 2017
11 October 2017
24 November 2017
3 May 2018
Types of concern Fabrication
Falsification
Plagiarism
Authorship misconduct
Study conduct and
governance irregularities
Implausible productivity
Implausible data
Data errors
Fabrication
Falsification
Plagiarism
Duplicate reporting
Authorship misconduct
Study conduct and
governance irregularities
Implausible productivity
Impossible data
Implausible data
Data errors
Funding unclear
Fabrication
Falsification
Plagiarism
Duplicate reporting
Authorship misconduct
Study conduct and
governance irregularities
Implausible productivity
Impossible data
Implausible data
Data errors
Funding unclear
Fabrication
Plagiarism
Duplicate reporting
Authorship misconduct
Study conduct and
governance irregularities
Impossible data
Data errors
Funding unclear
Detailed concerns raised about specific
publications
N Y Y Y
Employees affected,a N 4 4 6 2
Publications potentially affected,b N 49 200 68 34
aCo-author > 5 publications with primary respondent
bPapers authored by primary respondent with at least one co-author affiliated to the institution
Table 2 Scope and outcomes of investigations undertaken by four academic institutions
Institution
1a 2c 3 4
Investigations by academic institutions
Scope 38 papers, first author
primary respondent
7 papers, first author
primary respondent
Uncertain 5 papers, first author
primary respondent
Employees investigated,
N
Uncertain 1 Uncertain Uncertain
Date of report 17 November 2017 23 August 2018 Not
available
30 May 2018
Decisions Research misconduct primary respondent
No research misconduct other employees
associated with investigated papers
No misconduct Not
available
Duplicate reporting
present
‘Concerns about
integrity of research
well-justified’
Recommendations Retraction of 14 papers, 7 of which were
already retracted. Remaining 24 papers, no
clear evidence of fraud
Retraction of 2 papers, to be actioned by
primary respondent. Noted 1 existing
retraction, overlooked another.
Not
available
No action
Report publicly available Yesb No Not
applicable
No
Subsequent response
from our group
Raised specific concerns about 18 papers
for which the investigation could not
determine integrity
Reiterated concerns about > 100 papers Not
applicable
Concerns not
addressed
or resolved for
any publication
Current status Further investigation commenced Uncertain Ongoing Further investigation
commenced
aPreliminary investigation November 2016–January 2017, full investigation commenced March 2017
bJapanese language only
cEarlier investigation March 2016–January 2017
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deficiencies were widespread and occurred in each do-
main of the checklist, including the presentation of con-
cerns/allegations, scope of investigation, descriptions of
the investigating committee, its resources and conflicts,
description of evidence considered/not considered, clar-
ity of presentation of findings and conclusions, and sup-
port of conclusions by the evidence.
Specific and detailed concerns were raised about poten-
tially affected publications co-authored by employees at
institutions 2, 3 and 4. These concerns were wide-ranging,
including those about research governance, authorship
misconduct, implausible productivity and study conduct,
duplicate results reporting, impossible or implausible data,
and data errors (Table 1). Institution 3 has not disclosed
the outcomes of its investigation, but correspondence
from institutions 2 and 4 that reported to us the results of
the investigations did not address any of the specific con-
cerns about individual publications. In none of the reports
was it apparent that any institution had collaborated with
any of the other institutions. Each assessor of the reports
Table 3 Quality assessment of institutions’ reports on the investigation of research integrity
Institutiona
1 2 4
Scope
Includes executive summary No No No
Clear and understandable In part In part In part
Allegations clearly presented In part No No
Charge to committee clearly described No No No
Scope sufficient to address scientific integrity issues No No No
Investigative committee
Appropriately constituted Cannot assess Cannot assess Cannot assess
Any external members Yes Yes Cannot assess
Potential conflicts of interest reviewed No No No
Report indicates standards of due process and confidentiality followed No No No
Respondent had opportunity to identify conflicts Cannot assess Cannot assess Cannot assess
Any concern that committee lacked expertise and resources Yes Yes Yes
Evidence
Report indicates evidence sequestered and protected No No No
Description of evidence considered In part In part In part
Respondent offered opportunity to respond Cannot assess Cannot assess Cannot assess
Committee considered and addressed whether important evidence
was unavailable
In part Cannot assess In part
Explanation for failure to review seemingly pertinent evidence In part No No
Need for further evidence or additional analysis Yes Yes Yes
List of individuals interviewed No No No
Should others have been interviewed Cannot assess Cannot assess Yes
Additional questions that should have been asked or evidence
examined to reach a supportable conclusion
Yes Yes Yes
Conclusion
Report clearly states findings Yes In part In part
Report clearly states conclusions Yes In part In part
Evidence fully support conclusions Cannot assess No No
Articulates and applies institutional policies No No No
Recommendations clear and supported by report No No No
Report describes and addresses requirements of external sponsors’
regulations
No No No
Overall assessment Not acceptable Not acceptable Not acceptable
Derived from Gunsalus et al. Components considered to be adequately addressed are in italic type
aInstitution 3 has not reported the results of its investigation
Grey et al. Research Integrity and Peer Review             (2019) 4:3 Page 4 of 6
considered that the investigations focussed on potential
misconduct, restricted in definition to fabrication, falsifica-
tion and plagiarism, rather than the integrity of all poten-
tially affected publications. For example, the investigation
committee of institution 1 reserved judgement on 24/38
papers because it ‘did not obtain clear evidence of fraud
for these publications.’ When we subsequently communi-
cated specific concerns about a wide range of aspects of
the integrity of 18 of these 24 papers (concerns listed in
Table 1), institution 1 initiated further investigation.
After receiving each report, we raised or reiterated
many unresolved concerns with each institution, 2 of
which then commenced additional investigations.
Discussion
Institutional investigations are important in protecting
and restoring research integrity, but assessment of the
adequacy of the processes undertaken and the quality of
the ensuing reports is uncommon, in part because they
are often opaque and/or inaccessible, respectively [1, 6].
Only one of the three reports we analysed is publicly
available, so key stakeholders such as the wider research
community, health practitioners and patients are un-
aware of the existence of two of the investigations, let
alone their outcomes. In two cases, we do not know
whether the reports have been shared with regulatory
bodies. The investigations failed to assess the majority of
publications about which concerns were raised and,
when detailed concerns were raised about specific publi-
cations, did not address them. The reports of the investi-
gations were inadequate in almost every respect, as
judged by scoring using a quality checklist. They con-
trast markedly with a higher quality report of an institu-
tional investigation of a different case [7]. Consequently,
it is impossible to be confident that rigorous, compre-
hensive and objective investigations were undertaken.
The upshot is that the most important outcome, the val-
idity and reliability of the published research, remains
uncertain.
To our knowledge, few analyses of institutional investiga-
tions of research integrity have been undertaken, and we
are unware of analyses of investigations by multiple institu-
tions of a common set of concerns. The Retraction Watch
website reports the scarcity of information from institu-
tional investigations, which, when it is available, often
became so via legal proceedings or public records requests
[8]. Occasionally, high-profile cases have attracted editorial
commentary, which has been both complimentary [3] and
critical [6, 9] of the institutions’ performances. Overall,
there is disquiet about institutional investigative processes,
because of concerns about conflicts of interest, inadequate
oversight and too little transparency [1].
We found that that institutional investigations failed to
address all potentially affected papers and to address
detailed concerns about individual publications. The latter
observation is similar to that in an analysis of journal and
publisher responses to such concerns over research pub-
lished by the same group of researchers (data in submis-
sion). In that analysis, none of the 16 decision emails from
affected journals responded to all of the specific concerns
that had been raised about the relevant publication. We
cannot determine the reason for these findings. It could
be that the institutional investigations decided to focus on
a subset of potentially affected papers, did not seek the
evidence required to address all the concerns, or that evi-
dence was not available or provided, or that the investiga-
tion was conducted and/or the report was written without
consideration of those specific concerns. The considerable
scope of the concerns and the involvement of more than
one institution and more than one country might have in-
fluenced the quality of the investigations undertaken. The
lack of evidence in the reports of communication between
affected institutions also aligns with the very limited com-
munications that appeared to take place, at least to our
knowledge, between affected journals after concerns were
raised (data in submission).
Our assessment of two of the three available investiga-
tion reports suggested a much stronger focus on the
determination of misconduct, restricted in definition to
fabrication, falsification or plagiarism, than the evaluation
of research integrity; the third report was too vague to as-
sess in this regard. This observation is supported by the
failure of the investigations to address specific concerns
about the integrity of individual publications which in-
cluded those about research governance, authorship mis-
conduct, implausible productivity and study conduct,
duplicate results reporting, impossible or implausible data,
and data errors. We think this an important observation.
We suggest that the integrity of published research should
be the first priority of any investigation of concerns, as
integrity can be importantly compromised without evi-
dence of misconduct, particularly if narrow definitions of
the latter are applied. Conflating research integrity and
misconduct may inhibit achieving the critical goal of
protecting the integrity of the published literature.
Conclusions
Our analyses identify important deficiencies in the quality
and reporting of institutional investigation of concerns
about research integrity. They reinforce disquiet about the
ability of institutions to rigorously and objectively oversee
the integrity of research conducted by their own employees
and the lack of regulatory oversight. A possible solution is
the establishment of more efficient and adequately
resourced independent organisations with the authority
and expertise to undertake and report investigations, and
implement recommendations, including those which span
multiple institutions and countries.
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